ATE279183T1 - Verwendung von triclosan zur behandlung und prävention von mukositis - Google Patents

Verwendung von triclosan zur behandlung und prävention von mukositis

Info

Publication number
ATE279183T1
ATE279183T1 AT99100030T AT99100030T ATE279183T1 AT E279183 T1 ATE279183 T1 AT E279183T1 AT 99100030 T AT99100030 T AT 99100030T AT 99100030 T AT99100030 T AT 99100030T AT E279183 T1 ATE279183 T1 AT E279183T1
Authority
AT
Austria
Prior art keywords
triclosan
mucositis
prevention
treatment
amount
Prior art date
Application number
AT99100030T
Other languages
English (en)
Inventor
Barry Libin
Original Assignee
Dent Internat Corp I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/186,825 external-priority patent/US5945089A/en
Application filed by Dent Internat Corp I filed Critical Dent Internat Corp I
Application granted granted Critical
Publication of ATE279183T1 publication Critical patent/ATE279183T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99100030T 1998-10-06 1999-01-04 Verwendung von triclosan zur behandlung und prävention von mukositis ATE279183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16722598A 1998-10-06 1998-10-06
US09/186,825 US5945089A (en) 1998-11-05 1998-11-05 Method of treating mucositis

Publications (1)

Publication Number Publication Date
ATE279183T1 true ATE279183T1 (de) 2004-10-15

Family

ID=26862964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99100030T ATE279183T1 (de) 1998-10-06 1999-01-04 Verwendung von triclosan zur behandlung und prävention von mukositis

Country Status (4)

Country Link
EP (1) EP0992238B1 (de)
AT (1) ATE279183T1 (de)
DE (1) DE69921058T2 (de)
ES (1) ES2230747T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050142204A1 (en) * 2001-09-18 2005-06-30 Loetter Antonie P. Triclosan dosage form
GB2382342A (en) 2001-11-27 2003-05-28 Reckitt Benckiser Nv Water-softening tablet
GB2386612A (en) 2002-03-22 2003-09-24 Reckitt Benckiser Nv Cleaning method
GB2403719A (en) 2003-07-07 2005-01-12 Reckitt Benckiser Nv Water-softening method
DE102007002073A1 (de) 2007-01-09 2008-07-10 Matthias Habenicht Mittel zur Pflege und antimikrobiellen Behandlung der Haut
CN111939144A (zh) * 2020-09-28 2020-11-17 湛娜 三氯生的新应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS611615A (ja) * 1984-06-12 1986-01-07 Yougo Takaoka 水虫外用薬
US5279813A (en) * 1989-10-26 1994-01-18 Colgate-Palmolive Company Plaque inhibition with antiplaque oral composition dispensed from container having polymeric material in contact and compatible with the composition
GB9117140D0 (en) * 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
HU209370B (en) * 1992-06-18 1994-05-30 Fabulon Rg Kozmetikai Kft Preparatives for treatment and preventing inflammations and other damages of skin caused by bacteria, viruses or reactive free radicals of oxygen, as well as method for making said preparatives
US5236699A (en) * 1992-06-22 1993-08-17 Libin Barry M Antiplaque mouth rinse

Also Published As

Publication number Publication date
ES2230747T3 (es) 2005-05-01
EP0992238B1 (de) 2004-10-13
DE69921058D1 (de) 2004-11-18
DE69921058T2 (de) 2006-02-02
EP0992238A1 (de) 2000-04-12

Similar Documents

Publication Publication Date Title
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
PT627221E (pt) Substancias antagonistas p para o tratamento de emese
BR9806301A (pt) Composição para revestimento hidrofóbico/ oleofóbico, processo para formação de um revestimento hidrofóbico/ oleofóbico em um substrato, conjunto de tratamento hidrofóbico/ oleofóbico, sustrato equipado com um revestimento hidrofóbico/ oleofóbico, e, vidraça monolìtica, laminada ou multipla.
ATE283032T1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
DE69629578D1 (de) Verwendung von wenigstens einem no-synthase hemmer zur behandlung empfindlicher haut
BR0305671A (pt) Emprego de silanos em agentes cosméticos e processo para o tratamento capilar
PT1596880E (pt) Métodos e composições para suprimir a diferenciação de fibrócitos
PT1089744E (pt) Composicao neuroprotectora para a prevencao e/ou tratamento de perturbacoes nervosas e de comportamento devidas a estados de ansiedade ou de depressao
ATE555803T1 (de) Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
ATE362374T1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE69921058D1 (de) Verwendung von Triclosan zur Behandlung und Prävention von Mukositis
IL124236A (en) Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
BR9911897B1 (pt) composição de perfume, produto desodorante, e, processo de cosmético para a redução ou prevenção do mau cheiro do corpo.
DE69716056D1 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE273711T1 (de) Verwendung von niedermolekularem heparin zur behandlung und/oder prophylaxe motoneuronaler krankheiten
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
BRPI0413262A (pt) uso de pelo menos um composto, e, processo para o tratamento de fruta de caroço
ATE367164T1 (de) Verwendung von 4-thiouridin oder isomaltitol zur behandlung von entzündungen und/oder hämostasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties